Contact Information: Contact: Rachel Levine Director Corporate Development & Communications Cleveland BioLabs, Inc. T: (646) 284-9439 E: rlevine@cbiolabs.com
Cleveland BioLabs to Host Investor Update Conference Call on March 31
| Quelle: Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwire - March 25, 2009) - Cleveland BioLabs, Inc. (NASDAQ : CBLI ) today
announced that it will host a conference call at 10:00 a.m. EDT on March
31, to provide an update on the Company's development strategy and
timeline. The Company also announced that it has scheduled its 2009 annual
meeting of stockholders for June 25, 2009 in Buffalo, New York, for
stockholders of record on April 27, 2009.
Interested parties may participate by dialing 877-407-8031 (US) or
201-689-8031 (International) approximately five to ten minutes before the
call start time. A live Webcast of the conference call will be available
on the Cleveland BioLabs Web site at www.cbiolabs.com.
A replay of the call will be available starting on March 31, 2009, at 1:00
p.m. EDT through April 7, 2009 at 11:59 p.m. EDT. Interested parties may
access the replay by dialing 877-660-6853 (US) or 201-612-7415
(International) and entering account number 286 and conference ID number
317662. An archived Webcast of the conference call will be available on
the Cleveland BioLabs Web site at www.cbiolabs.com.
About Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. is a drug discovery and development company
leveraging its proprietary discoveries around programmed cell death to
treat cancer and protect normal tissues from exposure to radiation and
other stresses. The Company has strategic partnerships with the Cleveland
Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed
Forces Radiobiology Research Institute. To learn more about Cleveland
BioLabs, Inc., please visit the company's website at
http://www.cbiolabs.com.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of
this press release, and involve certain risks and uncertainties. The
Company's actual results could differ materially from those anticipated in
these forward-looking statements as a result of various factors. Some of
the factors that could cause future results to materially differ from the
recent results or those projected in forward-looking statements include the
"Risk Factors" described in the Company's periodic filings with the
Securities and Exchange Commission.